Tag: generic drug competition
How Second and Third Generic Drugs Drive Down Prescription Prices
Daniel Whiteside
Jan
6
2
Comments
Second and third generic drug manufacturers drive the biggest price drops in prescription medications, often cutting costs by 60% or more. Learn how competition after patent expiration saves patients billions.
More Detail
Patent Litigation: How Authorized Generics Reduce Generic Drug Competition
Daniel Whiteside
Dec
19
13
Comments
Authorized generics let brand drug companies launch their own generic versions, undercutting independent competitors during the 180-day exclusivity window. This practice reduces price drops, discourages patent challenges, and harms true competition in the pharmaceutical market.
More Detail